6.38
2.15%
-0.14
After Hours:
6.36
-0.02
-0.31%
Kezar Life Sciences Inc Stock (KZR) Forecast
The Kezar Life Sciences Inc (KZR) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.06, representing a +120.45% increase from the current price of $6.38. The highest analyst price target is $14.51, and the lowest is $13.62.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month KZR Price Target
Average 11.57
(+81.32% Upside)
Is Kezar Life Sciences Inc (KZR) A Buy Now?
Oscillators
Name | Value | Action |
---|---|---|
RSI(14) | 32.30 | Neutral |
STOCH(9,6) | 14.61 | Buy |
STOCHRSI(14) | 50.36 | Neutral |
MACD(12,26) | -0.2657 | Sell |
ADX(14) | 28.95 | Sell |
William %R | -82.11 | Buy |
CCI(14) | -53.36 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
Period | Simple | Exponential |
---|---|---|
MA10 |
6.661
Sell
|
6.6338
Sell
|
MA20 |
6.958
Sell
|
6.8626
Sell
|
MA50 |
7.4404
Sell
|
7.0814
Sell
|
MA100 |
6.8546
Sell
|
7.10
Sell
|
MA200 |
7.1908
Sell
|
7.5325
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, KZR could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on KZR, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 32.3 indicates that KZR is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 14.61 indicates that KZR is oversold. This indicates that KZR price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 50.36 indicates that KZR is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 28.95 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -53.36 indicates that KZR is still oversold but not to an extreme extent.
Long-term KZR price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Kezar Life Sciences Inc financial reports and earnings history, Kezar Life Sciences Inc (KZR) stock could reach $28.62 by 2030, $12.05 by 2040 and $30.62 by 2050. See the projected annual prices until 2050 of the Kezar Life Sciences Inc stock below:
- Kezar Life Sciences Inc (KZR) is expected to reach an average price of $4.2487 in 2035, with a high prediction of $4.8945 and a low estimate of $4.3405. This indicates an $-33.41% rise from the last recorded price of $6.38.
- Kezar Life Sciences Inc (KZR) stock is projected to chart a bullish course in 2040, with an average price target of $11.79, representing an $84.82% surge from its current level. The forecast ranges from a conservative $11.90 to a sky-high $12.05.
- Our analysts predict Kezar Life Sciences Inc (KZR) to jump 208.37% by 2045, soaring from $19.09 to an average price of $19.67, potentially reaching $18.60. While $19.09 is the low estimate, the potential upside is significant.
- Kezar Life Sciences Inc (KZR) stock is expected to climb by 2050, reaching an average of $29.07, a $355.59% jump from its current level. However, a wide range of estimates exists, with high and low targets of $30.62 and $30.92, respectively, highlighting the market's uncertainty.
Kezar Life Sciences Inc Stock (KZR) Year by Year Forecast
Kezar Life Sciences Inc Stock (KZR) Price Forecast for 2025
Kezar Life Sciences Inc Stock (KZR) is expected to reach an average price of $11.57 in 2025, with a high prediction of $14.51 and a low estimate of $8.6244. This indicates an +81.32% rise from the last recorded price of $6.38.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2025 | $13.20 | $13.62 | $14.51 | +106.88% |
February, 2025 | $13.79 | $13.81 | $13.59 | +116.22% |
March, 2025 | $12.18 | $11.70 | $12.94 | +90.92% |
April, 2025 | $12.27 | $12.29 | $12.11 | +92.37% |
May, 2025 | $11.56 | $11.70 | $11.95 | +81.18% |
June, 2025 | $10.56 | $10.92 | $11.21 | +65.44% |
July, 2025 | $9.6878 | $10.69 | $9.9718 | +51.85% |
August, 2025 | $10.12 | $10.06 | $9.7273 | +58.68% |
September, 2025 | $10.28 | $10.28 | $10.14 | +61.13% |
October, 2025 | $9.9424 | $9.9259 | $9.9963 | +55.84% |
November, 2025 | $9.4884 | $9.7054 | $9.6289 | +48.72% |
December, 2025 | $8.8609 | $8.6244 | $9.3949 | +38.89% |
Kezar Life Sciences Inc Stock (KZR) Price Forecast for 2026
The predicted value for Kezar Life Sciences Inc (KZR) in 2026 is set at an average of $5.315. Estimates vary from a peak of $8.2974 to a trough of $2.3326, indicating an -16.69% surge from the present price of $6.38.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2026 | $7.8169 | $8.3369 | $8.2974 | +22.52% |
February, 2026 | $8.0129 | $7.2999 | $7.2794 | +25.59% |
March, 2026 | $7.749 | $7.929 | $7.7995 | +21.46% |
April, 2026 | $6.8915 | $7.2315 | $7.5585 | +8.02% |
May, 2026 | $6.2775 | $6.6775 | $6.758 | -1.61% |
June, 2026 | $6.3835 | $6.4435 | $6.387 | +0.06% |
July, 2026 | $6.866 | $6.693 | $6.546 | +7.62% |
August, 2026 | $6.2121 | $6.3321 | $5.9121 | -2.63% |
September, 2026 | $5.7646 | $6.2616 | $6.0381 | -9.65% |
October, 2026 | $5.4306 | $6.3476 | $5.9441 | -14.88% |
November, 2026 | $3.4066 | $4.0766 | $5.0336 | -46.60% |
December, 2026 | $2.0491 | $2.3326 | $2.4131 | -67.88% |
Kezar Life Sciences Inc Stock (KZR) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Kezar Life Sciences Inc (KZR) is $5.0869, with a high forecast of $9.6522 and a low forecast of $0.5216. This indicates an -20.27% decrease from the last price of $6.38.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2027 | $1.8652 | $2.1957 | $1.9157 | -70.77% |
February, 2027 | $3.7688 | $2.2512 | $4.1488 | -40.93% |
March, 2027 | $4.7263 | $2.1663 | $5.6293 | -25.92% |
April, 2027 | $4.5703 | $3.3703 | $7.5233 | -28.37% |
May, 2027 | $3.4343 | $1.9073 | $4.4238 | -46.17% |
June, 2027 | $4.2417 | $3.3047 | $6.2735 | -33.52% |
July, 2027 | $7.8157 | $4.2052 | $9.6522 | +22.50% |
August, 2027 | $5.0497 | $5.0097 | $9.1227 | -20.85% |
September, 2027 | $2.9928 | $2.2933 | $5.6032 | -53.09% |
October, 2027 | $2.6889 | $3.1743 | $2.8793 | -57.85% |
November, 2027 | $2.6251 | $0.5216 | $3.1681 | -58.85% |
December, 2027 | $2.9426 | $1.7986 | $3.4026 | -53.88% |
Kezar Life Sciences Inc Stock (KZR) Price Forecast for 2028
In 2028, Kezar Life Sciences Inc (KZR) is projected to reach an average price of $1.783, with a high projection of $3.4996 and a low estimate of $0.0664. This indicates an -72.05% fall from the last price of $6.38.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2028 | $2.6966 | $2.3131 | $3.4996 | -57.73% |
February, 2028 | $1.7106 | $0.7571 | $3.4836 | -73.19% |
March, 2028 | $0.933 | $0.3811 | $2.1541 | -85.38% |
April, 2028 | $1.132 | $0.105 | $1.8585 | -82.26% |
May, 2028 | $0.8295 | $0.5195 | $1.689 | -87.00% |
June, 2028 | $0.6635 | $0.07 | $1.55 | -89.60% |
July, 2028 | $1.0275 | $0.597 | $1.874 | -83.90% |
August, 2028 | $0.5451 | $0.0664 | $1.291 | -91.46% |
September, 2028 | $2.4211 | $1.5716 | $1.7611 | -62.05% |
October, 2028 | $2.0371 | $2.3271 | $2.3176 | -68.07% |
November, 2028 | $1.4996 | $1.6346 | $1.8736 | -76.49% |
December, 2028 | $1.6556 | $1.8156 | $1.6356 | -74.05% |
Kezar Life Sciences Inc Stock (KZR) Price Forecast for 2029
The 2029 price forecast for Kezar Life Sciences Inc Stock (KZR) is $8.9699 on average, with a high prediction of $17.88 and a low estimate of $0.0569. This represents an +40.59% increase from the previous price of $6.38.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2029 | $1.5482 | $1.5686 | $1.5571 | -75.73% |
February, 2029 | $1.8842 | $1.6047 | $2.0077 | -70.47% |
March, 2029 | $1.9902 | $1.9072 | $1.9802 | -68.81% |
April, 2029 | $2.0696 | $2.0732 | $1.9332 | -67.56% |
May, 2029 | $1.9914 | $2.0087 | $2.0587 | -68.79% |
June, 2029 | $1.6167 | $1.6348 | $1.7552 | -74.66% |
July, 2029 | $1.2534 | $1.3808 | $1.5033 | -80.35% |
August, 2029 | $0.8938 | $1.0633 | $1.1598 | -85.99% |
September, 2029 | $0.7291 | $0.8238 | $0.8218 | -88.57% |
October, 2029 | $0.3373 | $0.4818 | $0.4758 | -94.71% |
November, 2029 | $0.2679 | $0.2878 | $0.2584 | -95.80% |
December, 2029 | $18.63 | $0.0569 | $17.88 | +192.05% |
Kezar Life Sciences Inc Stock (KZR) Price Forecast for 2030
Kezar Life Sciences Inc Stock (KZR) is expected to reach an average price of $26.17 in 2030, with a high forecast of $32.99 and a low forecast of $19.36. This signifies an +310.21% surge from the last price of $6.38.
Month | Average | Low | High | Change from today's price |
---|---|---|---|---|
January, 2030 | $29.19 | $19.36 | $28.62 | +357.49% |
February, 2030 | $30.67 | $30.48 | $30.11 | +380.72% |
March, 2030 | $32.04 | $31.88 | $31.56 | +402.23% |
April, 2030 | $33.39 | $32.74 | $32.71 | +423.42% |
May, 2030 | $32.94 | $33.18 | $32.99 | +416.29% |
June, 2030 | $32.24 | $32.33 | $32.64 | +405.27% |
July, 2030 | $32.12 | $32.24 | $32.12 | +403.47% |
August, 2030 | $31.05 | $31.91 | $31.96 | +386.65% |
September, 2030 | $30.73 | $30.74 | $30.41 | +381.67% |
October, 2030 | $28.01 | $28.53 | $30.40 | +338.96% |
November, 2030 | $29.64 | $28.31 | $28.12 | +364.54% |
December, 2030 | $28.74 | $28.57 | $28.47 | +350.46% |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):